Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone LAI Resource Utilization Pilot
NCT00272597Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Sep 2005
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by University of British Columbia. Started Sep 2005; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00272597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272597.